Veru is an oncology biopharmaceutical company with a focus on developing novel medicines for the management of breast cancer and prostate cancer. Our strategy is primarily to focus on the clinical development and commercialization of oncology drugs for the management of two of the most prevalent cancers globally – breast cancer and prostate cancer. Disclaimer: https://verupharma.com/online-privacy-policy/